TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 3, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy and Safety of a Single Oral Administration of Nolasiban to Improve Pregnancy Rates Following IVF or ICSI in Day 3 and Day 5 Fresh Embryo Transfer Cycles
Brief Summary: The primary objective of this study is to confirm the efficacy of a single oral 900mg dose of nolasiban to increase the ongoing clinical pregnancy rate at 10 weeks post embryo transfer (ET) day.


Options:
A: Arm Label: Biopsy catheter; Type: EXPERIMENTAL; Interventions: Procedure: Endometrial biopsy | Intervention Type: PROCEDURE; Name: Endometrial biopsy; Assigned to Arm(s): Biopsy catheter | Intervention Type: PROCEDURE; Name: Endometrial Biopsy; Assigned to Arm(s): Biopsy catheter
B: Arm Label: Nolasiban 900 mg; Type: EXPERIMENTAL; Interventions: Drug: Nolasiban 900mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Nolasiban 900mg; Assigned to Arm(s): Nolasiban 900 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Atosiban used before embryo transfer; Type: EXPERIMENTAL; Interventions: Drug: Atosiban | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Atosiban used before embryo transfer
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Procedure: PIPELLE ENDOMETRIAL SAMPLING | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: PIPELLE ENDOMETRIAL SAMPLING; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV: Project AVAST - HIV
Brief Summary: The proposed pilot study seeks to address the smoking treatment needs of people living with HIV/AIDS (PLWHA) by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treatment content to be presented with voice/audio, images, videos, and text in an interactive, structured format anytime and anywhere. This automated treatment approach is designed to enhance treatment engagement and facilitate abstinence from smoking among PLWHA. Participants will be recruited from the University of Oklahoma Health Sciences Center (OUHSC) clinics providing care to HIV+ individuals (e.g., the Infectious Diseases Institute).


Options:
A: Arm Label: Standard Treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Behavioral: Counseling | Arm Label: Automated Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Self-help materials, Drug: nicotine patch, Other: Smartphone-delivered automated treatment | Intervention Type: BEHAVIORAL; Name: Self-help materials; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): Automated Treatment, Standard Treatment | Intervention Type: BEHAVIORAL; Name: Counseling; Assigned to Arm(s): Standard Treatment | Intervention Type: OTHER; Name: Smartphone-delivered automated treatment; Assigned to Arm(s): Automated Treatment
B: Arm Label: Individualized, interactive SMS; Type: EXPERIMENTAL; Interventions: Behavioral: Individualized, interactive short messaging intervention | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Individualized, interactive short messaging intervention; Assigned to Arm(s): Individualized, interactive SMS
C: Arm Label: Health-E You App Participants; Type: EXPERIMENTAL; Interventions: Behavioral: Health-E You: a computer-based intervention to improve the use of effective contraception among Hispanic adolescents | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Health-E You: a computer-based intervention to improve the use of effective contraception among Hispanic adolescents; Assigned to Arm(s): Health-E You App Participants
D: Arm Label: Mobile phone text message; Type: EXPERIMENTAL; Interventions: Other: Mobile phone text message | Arm Label: No Mobile phone text message; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Mobile phone text message; Assigned to Arm(s): Mobile phone text message | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): No Mobile phone text message

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Randomized Controlled Trial of Aerobic Exercise in Rectal Cancer Patients During and After Neoadjuvant Chemoradiotherapy
Brief Summary: This study is designed to investigate if aerobic exercise during and after neoadjuvant chemoradiotherapy (NACRT) can improve outcomes for rectal cancer patients.


Options:
A: Arm Label: Rectal Cancer; Type: N/A; Interventions: N/A
B: Intervention Type: BEHAVIORAL; Name: exercise intervention; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: complementary or alternative medicine procedure; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fatigue assessment and management; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: physical therapy; Assigned to Arm(s): N/A
C: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial rehabilitation course | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychosocial rehabilitation course; Assigned to Arm(s): Intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase II Randomized Controlled Trial of Aerobic Exercise in Rectal Cancer Patients During and After Neoadjuvant Chemoradiotherapy
Brief Summary: This study is designed to investigate if aerobic exercise during and after neoadjuvant chemoradiotherapy (NACRT) can improve outcomes for rectal cancer patients.


Options:
A: Arm Label: Exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Exercise | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional resistance training | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Other: Whole body vibration resistance training | Intervention Type: OTHER; Name: Conventional resistance training; Assigned to Arm(s): 2 | Intervention Type: OTHER; Name: Whole body vibration resistance training; Assigned to Arm(s): 3
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and relaxation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and physical activity | Arm Label: 4; Type: NO_INTERVENTION; Interventions: Other: Control group | Intervention Type: BEHAVIORAL; Name: CBT and relaxation; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CBT and physical activity; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): 4
D: Arm Label: Linear Aerobic Training; Type: EXPERIMENTAL; Interventions: Behavioral: Linear Aerobic Training, Other: Cardiopulmonary exercise test (CPET), Other: Blood draws | Arm Label: Nonlinear Aerobic Training; Type: EXPERIMENTAL; Interventions: Behavioral: Nonlinear Aerobic Training, Other: Cardiopulmonary exercise test (CPET), Other: Blood draws | Arm Label: Progressive Stretching Group (Attention control); Type: EXPERIMENTAL; Interventions: Behavioral: Progressive Stretching, Other: Cardiopulmonary exercise test (CPET), Other: Blood draws | Intervention Type: BEHAVIORAL; Name: Linear Aerobic Training; Assigned to Arm(s): Linear Aerobic Training | Intervention Type: BEHAVIORAL; Name: Nonlinear Aerobic Training; Assigned to Arm(s): Nonlinear Aerobic Training | Intervention Type: BEHAVIORAL; Name: Progressive Stretching; Assigned to Arm(s): Progressive Stretching Group (Attention control) | Intervention Type: OTHER; Name: Cardiopulmonary exercise test (CPET); Assigned to Arm(s): Linear Aerobic Training, Nonlinear Aerobic Training, Progressive Stretching Group (Attention control) | Intervention Type: OTHER; Name: Blood draws; Assigned to Arm(s): Linear Aerobic Training, Nonlinear Aerobic Training, Progressive Stretching Group (Attention control)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Topical Magnesium Supplementation for the Treatment of Muscle Cramps in Dialysis Patients
Brief Summary: Oral magnesium supplementation has been widely used in the treatment of muscle cramps. Muscle cramps are common in dialysis patients but are not satisfactorily prevented by oral magnesium. Transdermal administration of magnesium has been promoted as a potential treatment for muscle cramps but this has not been investigated rigorously. We aim to evaluate the effectiveness of transdermal magnesium supplementation in reducing cramp frequency and severity. We will recruit current haemodialysis patients who suffer from muscle cramps into a randomised, placebo-controlled, cross-over design trial. Each intervention period will last 8 weeks with a 4-week washout period in between. We will measure muscle cramp frequency, duration and severity as the primary outcomes.


Options:
A: Arm Label: exercise; Type: EXPERIMENTAL; Interventions: Other: Fitness exercise program | Intervention Type: OTHER; Name: Fitness exercise program; Assigned to Arm(s): exercise
B: Arm Label: Transdermal Magnesium; Type: EXPERIMENTAL; Interventions: Drug: Transdermal Magnesium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Transdermal Magnesium; Assigned to Arm(s): Transdermal Magnesium | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Physical training - No encephalopathy; Type: EXPERIMENTAL; Interventions: Other: Physical training, Other: Diet intervention | Arm Label: Control - No encephalopathy; Type: ACTIVE_COMPARATOR; Interventions: Other: Diet intervention | Arm Label: Physical training - Early encephalopathy; Type: EXPERIMENTAL; Interventions: Other: Physical training, Other: Diet intervention | Arm Label: Control - Early encephalopathy; Type: ACTIVE_COMPARATOR; Interventions: Other: Diet intervention | Intervention Type: OTHER; Name: Physical training; Assigned to Arm(s): Physical training - Early encephalopathy, Physical training - No encephalopathy | Intervention Type: OTHER; Name: Diet intervention; Assigned to Arm(s): Control - Early encephalopathy, Control - No encephalopathy, Physical training - Early encephalopathy, Physical training - No encephalopathy
D: Arm Label: MAGNOX 520®; Type: EXPERIMENTAL; Interventions: Drug: MAGNOX 520® | Arm Label: Similarly looking placebo.; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: MAGNOX 520®; Assigned to Arm(s): MAGNOX 520® | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Similarly looking placebo.

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
Brief Summary: Nighttime agitation in persons with Alzheimer's disease causes patient suffering, distresses caregivers, and often results in prescriptions for harmful antipsychotics. Effective treatments are lacking because of limited knowledge of the etiology of nighttime agitation. The investigators propose a clinical trial to better elucidate whether a sleep disorder, restless legs syndrome, may be a mechanism for nighttime agitation, and if treatment with gabapentin enacarbil (Horizant®) reduces nighttime agitation, improves sleep, reduces restless legs syndrome behaviors, and reduces antipsychotic medications.


Options:
A: Intervention Type: DRUG; Name: galantamine; Assigned to Arm(s): N/A
B: Arm Label: Ramelteon 8 mg QD; Type: EXPERIMENTAL; Interventions: Drug: Ramelteon | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Ramelteon; Assigned to Arm(s): Ramelteon 8 mg QD | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Gabapentin Enacarbil (GEn); Type: EXPERIMENTAL; Interventions: Drug: Gabapentin Enacarbil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet | Intervention Type: DRUG; Name: Gabapentin Enacarbil; Assigned to Arm(s): Gabapentin Enacarbil (GEn) | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Placebo
D: Arm Label: Zolpidem CR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zolpidem CR | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zolpidem CR; Assigned to Arm(s): Zolpidem CR | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Randomized Controlled Trial of a Web-based Intervention Using Behavioral Activation and Physical Activity for Adults With Depression: the eMotion Study.
Brief Summary: Physical activity has many potential mood enhancing benefits, and may be as effective as anti-depressants and psychological therapies for treating depression and low mood. However, getting people with depression to become more active is challenging. Behavioural Activation (BA) is an evidenced based psychotherapeutic treatment that focuses on increasing exposure to positive environmental stimuli which could provide an effective delivery mechanism for increasing physical activity for people who are more sedentary than the general population. The purpose of this study is to examine the feasibility of delivering a theory informed online intervention combining physical activity and BA (eMotion) to people with depression, and to examine its effects on depressive symptoms and physical activity.


Options:
A: Arm Label: 4 face-to-face and smartphone-app; Type: EXPERIMENTAL; Interventions: Behavioral: 4 face-to-face therapy session and a smartphone-app | Arm Label: TAU; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT, treatment as usual | Intervention Type: BEHAVIORAL; Name: 4 face-to-face therapy session and a smartphone-app; Assigned to Arm(s): 4 face-to-face and smartphone-app | Intervention Type: BEHAVIORAL; Name: CBT, treatment as usual; Assigned to Arm(s): TAU
B: Arm Label: Support Group (Control Group); Type: OTHER; Interventions: Behavioral: Support Group | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: Support Group; Assigned to Arm(s): Support Group (Control Group)
C: Arm Label: eMotion intervention; Type: EXPERIMENTAL; Interventions: Behavioral: eMotion | Arm Label: Waiting list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: eMotion; Assigned to Arm(s): eMotion intervention
D: Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: Behavioral Activation; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Activation | Arm Label: non-specific counseling; Type: EXPERIMENTAL; Interventions: Behavioral: nonspecific counseling | Arm Label: wait control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Behavioral Activation; Assigned to Arm(s): Behavioral Activation | Intervention Type: BEHAVIORAL; Name: nonspecific counseling; Assigned to Arm(s): non-specific counseling

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Changes in Biomarkers Associated With Use of Electronic Cigarettes Among African American Menthol and Nonmenthol Smokers
Brief Summary: The objective of this clinical trial was to compare the effects of e-cigarettes with and without nicotine on patterns of combustible cigarette use and biomarkers of exposure to tobacco toxicants among African American smokers.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Naltrexone, Drug: Varenicline | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline | Intervention Type: DRUG; Name: Naltrexone; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Varenicline; Assigned to Arm(s): 1, 2
B: Arm Label: Varenicline and Placebo Patch; Type: PLACEBO_COMPARATOR; Interventions: Drug: Varenicline and Placebo Patch | Arm Label: Varenicline and Nicotine Patch; Type: ACTIVE_COMPARATOR; Interventions: Drug: Varenicline, Nicotine Patch | Intervention Type: DRUG; Name: Varenicline, Nicotine Patch; Assigned to Arm(s): Varenicline and Nicotine Patch | Intervention Type: DRUG; Name: Varenicline and Placebo Patch; Assigned to Arm(s): Varenicline and Placebo Patch
C: Arm Label: E-Cig Zero Nicotine; Type: SHAM_COMPARATOR; Interventions: Device: E-Cig Zero Nicotine | Arm Label: E-Cig 24mg Nicotine; Type: ACTIVE_COMPARATOR; Interventions: Device: E-Cig 24mg Nicotine | Intervention Type: DEVICE; Name: E-Cig Zero Nicotine; Assigned to Arm(s): E-Cig Zero Nicotine | Intervention Type: DEVICE; Name: E-Cig 24mg Nicotine; Assigned to Arm(s): E-Cig 24mg Nicotine
D: Arm Label: Monotherapy (Cytisine only); Type: ACTIVE_COMPARATOR; Interventions: Drug: Cytisine | Arm Label: Monotherapy (Nicotine e-cigarette only); Type: ACTIVE_COMPARATOR; Interventions: Drug: Nicotine delivered via an e-cigarette | Arm Label: Combination therapy (Cytisine plus a nicotine e-cigarette); Type: ACTIVE_COMPARATOR; Interventions: Combination Product: Cytisine plus nicotine delivered via an e-cigarette | Intervention Type: DRUG; Name: Cytisine; Assigned to Arm(s): Monotherapy (Cytisine only) | Intervention Type: DRUG; Name: Nicotine delivered via an e-cigarette; Assigned to Arm(s): Monotherapy (Nicotine e-cigarette only) | Intervention Type: COMBINATION_PRODUCT; Name: Cytisine plus nicotine delivered via an e-cigarette; Assigned to Arm(s): Combination therapy (Cytisine plus a nicotine e-cigarette)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Changes in Biomarkers Associated With Use of Electronic Cigarettes Among African American Menthol and Nonmenthol Smokers
Brief Summary: The objective of this clinical trial was to compare the effects of e-cigarettes with and without nicotine on patterns of combustible cigarette use and biomarkers of exposure to tobacco toxicants among African American smokers.


Options:
A: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual Care | Arm Label: Brief Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Brief Intervention | Arm Label: Extended Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: Extended Treatment | Intervention Type: BEHAVIORAL; Name: Brief Intervention; Assigned to Arm(s): Brief Treatment | Intervention Type: BEHAVIORAL; Name: Extended Treatment; Assigned to Arm(s): Extended Treatment | Intervention Type: BEHAVIORAL; Name: Usual Care; Assigned to Arm(s): Usual Care
B: Arm Label: Nicotine; Type: EXPERIMENTAL; Interventions: Behavioral: Smoking cessation program TFC and activity tracker | Arm Label: Nicotine-free; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Smoking cessation program TFC-free and activity tracker | Arm Label: No-cig; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Smoking cessation program and activity tracker | Intervention Type: BEHAVIORAL; Name: Smoking cessation program TFC and activity tracker; Assigned to Arm(s): Nicotine | Intervention Type: BEHAVIORAL; Name: Smoking cessation program TFC-free and activity tracker; Assigned to Arm(s): Nicotine-free | Intervention Type: BEHAVIORAL; Name: Smoking cessation program and activity tracker; Assigned to Arm(s): No-cig
C: Arm Label: E-Cig Zero Nicotine; Type: SHAM_COMPARATOR; Interventions: Device: E-Cig Zero Nicotine | Arm Label: E-Cig 24mg Nicotine; Type: ACTIVE_COMPARATOR; Interventions: Device: E-Cig 24mg Nicotine | Intervention Type: DEVICE; Name: E-Cig Zero Nicotine; Assigned to Arm(s): E-Cig Zero Nicotine | Intervention Type: DEVICE; Name: E-Cig 24mg Nicotine; Assigned to Arm(s): E-Cig 24mg Nicotine
D: Arm Label: Electronic cigarette condition; Type: EXPERIMENTAL; Interventions: Drug: Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline | Arm Label: Varenicline condition; Type: ACTIVE_COMPARATOR; Interventions: Drug: Electronic cigarette without nicotine (ECwN) plus active varenicline tablets | Arm Label: Placebo condition; Type: PLACEBO_COMPARATOR; Interventions: Drug: Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline | Intervention Type: DRUG; Name: Electronic cigarette without nicotine (ECwN) plus active varenicline tablets; Assigned to Arm(s): Varenicline condition | Intervention Type: DRUG; Name: Electronic cigarette without nicotine (ECwoN) plus placebo tablets of varenicline; Assigned to Arm(s): Placebo condition | Intervention Type: DRUG; Name: Electronic cigarette with nicotine (ECwN) plus placebo tablets of varenicline; Assigned to Arm(s): Electronic cigarette condition

Answer: C